Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
5,138,616
-
Total 13F shares
-
499,475
-
Share change
-
+475,876
-
Total reported value
-
$514,455
-
Price per share
-
$1.03
-
Number of holders
-
16
-
Value change
-
+$490,133
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of RedHill Biopharma Ltd. - American Depositary Shares (RDHL) as of Q4 2025
As of 31 Dec 2025,
RedHill Biopharma Ltd. - American Depositary Shares (RDHL) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
499,475 shares.
The largest 10 holders included
Yorkville Advisors Global, LP, GAGNON SECURITIES LLC, CITADEL ADVISORS LLC, GAMMA Investing LLC, Federation des caisses Desjardins du Quebec, RHUMBLINE ADVISERS, BANK OF AMERICA CORP /DE/, EverSource Wealth Advisors, LLC, Your Advocates Ltd., LLP, and UBS Group AG.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.